EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Treatment patterns and survival outcomes according to histologic subtype in malignant ovarian germ cell tumors: a nationwide real-world cohort study

Jaekyung Bae iD, Byeong-Chan Oh iD, Uisuk Kim iD, Junyoung Shin iD, Sokbom Kang iD

Journal of Gynecologic Oncology · 2026

DOI: 10.3802/jgo.2026.37.e60 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Jaekyung Bae und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Neoplasms, Germ Cell and Embryonal. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate real-world treatment patterns and survival outcomes by histologic subtype in patients with malignant ovarian germ cell tumors (MOGCTs) in Korea. METHODS: Using the Cancer Public Library Database, a retrospective cohort study was conducted including adult patients newly diagnosed with MOGCTs between 2013 and 2018. Patients were categorized into 3 histologic subtypes: dysgerminoma, non-dysgerminomatous germ cell tumors (ND-GCTs; yolk sac tumor, embryonal carcinoma, and mixed germ cell tumor [GCT]), and malignant teratomatous germ cell tumors (immature teratoma and teratocarcinoma). Initial treatment patterns, including surgery and chemotherapy, were examined. Overall survival (OS) was assessed by histologic subtype using the Kaplan-Meier method. In localized-stage patients, OS and time to first subsequent therapy or death (TFST) were estimated by adjuvant chemotherapy use, with subgroup analysis by histology. RESULTS: A total of 332 patients were included (27.7% dysgerminomas, 33.4% ND-GCTs, 38.9% malignant teratomatous GCTs). In localized disease, surgery alone was common in dysgerminomas (57.6%), while adjuvant chemotherapy was frequently used in ND-GCTs (88.5%) and malignant teratomatous GCTs (60.0%). Adjuvant chemotherapy was associated with longer TFST overall (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsNeoplasms, Germ Cell and EmbryonalHumansFemaleAdultRetrospective StudiesChemotherapy, AdjuvantRepublic of KoreaMiddle AgedDysgerminomaTeratomaYoung AdultCohort StudiesTreatment Outcome

Stichwörter der Autor:innen

Chemotherapy, AdjuvantNeoplasms, Germ Cell and EmbryonalOvarian Neoplasms

Autor:innen und Institutionen

  • Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea.
  • Cancer Outcome & Quality Improvement Branch, National Cancer Center, Goyang, Korea.
  • Department of Pathology, National Cancer Center, Goyang, Korea.
  • Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea. sokbom@ncc.re.kr.

ORCID-Profile: Jaekyung Bae, Byeong-Chan Oh, Uisuk Kim, Junyoung Shin, Sokbom Kang

Förderung

  • National Cancer Center

Zitieren

APA

Bae, J., Oh, B. C., Kim, U., Shin, J., & Kang, S. (2026). Treatment patterns and survival outcomes according to histologic subtype in malignant ovarian germ cell tumors: a nationwide real-world cohort study. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e60

Vancouver

Bae J, Oh BC, Kim U, Shin J, Kang S. Treatment patterns and survival outcomes according to histologic subtype in malignant ovarian germ cell tumors: a nationwide real-world cohort study. Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e60

BibTeX
@article{Bae2026,
  author = {Bae, Jaekyung and Oh, Byeong-Chan and Kim, Uisuk and Shin, Junyoung and Kang, Sokbom},
  title = {Treatment patterns and survival outcomes according to histologic subtype in malignant ovarian germ cell tumors: a nationwide real-world cohort study},
  journal = {Journal of Gynecologic Oncology},
  year = {2026},
  doi = {10.3802/jgo.2026.37.e60}
}
Kostenlos starten →